Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Imugene says HER-Vaxx cancer vaccine induces 50% ORR in stomach cancer trial

firstwordpharmaJuly 06, 2021

Tag: Imugene , HER-Vaxx , stomach cancer

PharmaSources Customer Service